STAT3-NAV2 axis as a new therapeutic target for rheumatoid arthritis via activating SSH1L/Cofilin-1 signaling pathway
Open Access
- 8 July 2022
- journal article
- letter
- Published by Springer Nature in Signal Transduction and Targeted Therapy
- Vol. 7 (1) , 1-4
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Neuron navigator 2 is a novel mediator of rheumatoid arthritisCellular & Molecular Immunology, 2021
- Neuronal interleukin-1 receptors mediate pain in chronic inflammatory diseasesJournal of Experimental Medicine, 2020
- Super-enhancer function and its application in cancer targeted therapynpj Precision Oncology, 2020
- Diagnosis and Management of Rheumatoid ArthritisJAMA, 2018
- Neuron navigator 2 overexpression indicates poor prognosis of colorectal cancer and promotes invasion through the SSH1L/cofilin-1 pathwayJournal of Experimental & Clinical Cancer Research, 2015